PX1 Research provides analytical-grade KPV (Lys-Pro-Val) tripeptide synthesized for qualified domestic laboratories. Every batch undergoes rigorous ISO 17025 third-party testing, including RP-HPLC purity verification, mass spectrometry sequence confirmation, and endotoxin analysis to ensure maximum experimental reproducibility in preclinical models.
PX1 Research provides analytical-grade KPV (Lys-Pro-Val) tripeptide synthesized for qualified domestic laboratories. Every batch undergoes rigorous ISO 17025 third-party testing, including RP-HPLC purity verification, mass spectrometry sequence confirmation, and endotoxin analysis to ensure maximum experimental reproducibility in preclinical models.
Investigators seeking to buy KPV in the USA require analytical-grade tripeptide (Lysine-Proline-Valine) verified for structural sequence, identity, and high sequence purity. PX1 Research synthesizes and supplies KPV for laboratory research use only, backed by lot-specific Certificates of Analysis, high-performance liquid chromatography (HPLC), mass spectrometry (MS), and quantitative endotoxin testing. Operating out of domestic manufacturing and distribution facilities in California and Arizona, PX1 Research provides verified reference standards that eliminate supply-chain variability for cellular assays and animal models.
KPV is a C-terminal tripeptide fragment derived from alpha-Melanocyte-Stimulating Hormone (alpha-MSH). In preclinical investigations, this non-cytotoxic peptide sequence has demonstrated significant anti-inflammatory and mucosal-protective properties without exhibiting the pigmentary melanocortin receptor activity associated with the full-length parent hormone. For domestic research institutions, securing KPV with verified peptide content, low trifluoroacetate (TFA) counterion levels, and confirmed stability is essential for maintaining strict experimental controls.
KPV is composed of three amino acid residues: L-Lysine, L-Proline, and L-Valine. It corresponds to amino acids 11 through 13 at the carboxy-terminus of alpha-MSH (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2). While alpha-MSH binds broadly across melanocortin receptors (MC1R through MC5R), the shortened KPV tripeptide structure retains anti-inflammatory signaling capabilities while exhibiting minimal affinity for classical pigment-modulating receptors.
With a molecular weight of approximately 383.48 g/mol, KPV is a low-molecular-weight peptide that demonstrates favorable cellular permeability compared to larger biomolecules. In vitro research indicates that the structural arrangement of the Lys-Pro-Val sequence is crucial for its biochemical activity; modifications to the amino acid order or stereochemistry significantly diminish its anti-inflammatory potency in cell culture models.
Preclinical studies suggest that the primary anti-inflammatory mechanism of KPV involves the inhibition of Nuclear Factor kappa B (NF-κB) activation pathways. NF-κB functions as a primary transcription factor governing the expression of pro-inflammatory cytokines, chemokines, and adhesion molecules. In vitro data indicate that KPV translocates into the cytoplasm and nucleus of target cells, where it suppresses the phosphorylation and degradation of IκBα, thereby preventing the translocation of the NF-κB p65 subunit to the nucleus.
By modulating NF-κB activity, KPV has been shown in laboratory models to downregulate the transcription of several key pro-inflammatory mediators, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Interleukin-8 (IL-8). Additionally, researchers evaluating cellular transport mechanisms have identified that KPV is transported into intestinal epithelial cells via the Peptide Transporter 1 (PepT1/SLC15A1), a solute carrier responsible for uptake of short di- and tripeptides. This transporter-mediated uptake allows KPV to accumulate intracellularly and exert localized anti-inflammatory effects directly within mucosal tissues.
A major area of preclinical focus for KPV involves its role in maintaining epithelial tight junction architecture and modulating gastrointestinal inflammation. In murine models of chemical-induced colitis—such as those utilizing Dextran Sulfate Sodium (DSS) or Trinitrobenzene Sulfonic Acid (TNBS)—administration of KPV resulted in measurable reductions in histologic inflammation scores, mucosal damage, and myeloperoxidase (MPO) activity.
In vitro intestinal barrier assays using Caco-2 cell monolayers demonstrate that KPV exposure helps preserve transepithelial electrical resistance (TEER) following challenge with pro-inflammatory cytokines. Mechanistic evaluations indicate that KPV assists in preserving the structural distribution of key tight junction proteins, including Zonula Occludens-1 (ZO-1) and Occludin. Researchers investigating gastrointestinal pathology often source KPV to evaluate its capacity to mitigate barrier disruption and reduce localized mucosal inflammation alongside other established tissue-repair molecules in our complete research peptide collection.
Beyond intestinal barrier studies, KPV has been extensively investigated in cutaneous inflammation and wound-healing assays. In preclinical models of contact hypersensitivity and allergic contact dermatitis, KPV application altered dendritic cell migration and suppressed local edema formation. Keratinocyte culture experiments show reduced expression of intercellular adhesion molecule-1 (ICAM-1) following KPV treatment under stimulated conditions.
Furthermore, in vitro microbiological assays indicate that KPV possesses inherent antimicrobial properties against specific pathogens, notably *Candida albicans*. Research suggests that KPV inhibits *C. albicans* germ tube formation—a primary virulence factor—at micromolar concentrations. The dual anti-inflammatory and antimicrobial profile observed in preclinical literature makes KPV a valuable target for investigators studying dermatological barrier dynamics and microbial-host interactions.
When designing protocols for inflammatory cascade modulation or mucosal repair, researchers frequently compare KPV against other prominent research peptides within the same signaling pathways. While KPV functions primarily via PepT1 cellular uptake and intracellular NF-κB suppression, compounds such as BPC-157 operate through distinct angiogenic, growth factor upregulation, and nitric oxide pathways to promote tissue healing. In intestinal permeability assays, researchers also examine tight-junction regulators like Larazotide Acetate, which acts extracellularly as a zonulin antagonist, contrasting with KPV's direct cytosolic cytokine modulation.
Additionally, when antimicrobial signaling is evaluated alongside immunomodulation, scientists often compare KPV to host-defense peptides like LL-37. While LL-37 exerts direct membrane-disrupting antimicrobial action and broad immune receptor activation, KPV offers a targeted anti-inflammatory profile with minimal cytotoxic activity, allowing researchers to isolate NF-κB-dependent cellular responses without inducing non-specific cell lysis.
To ensure reproducible experimental outcomes, research institutions sourcing KPV within the United States must strictly verify batch quality prior to laboratory deployment. PX1 Research adheres to rigorous quality control protocols to supply analytical-grade reagents that meet strict academic and industrial standards. Every lot of KPV undergoes comprehensive testing at accredited domestic facilities:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Confirms peptide purity levels exceed 99.0%, ensuring the absence of truncated sequences or synthesis side-products. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass (383.48 g/mol) and structural identity. 3. Endotoxin Quantitation (LAL Assay): Ensures bacterial endotoxin levels remain below strictly defined limits (<0.01 EU/mg), preventing confounding inflammatory activation in cell cultures. 4. Trifluoroacetate (TFA) Analysis: Monitors residual counterion levels to prevent unexpected cell toxicity during sensitive in vitro assays. 5. ISO 17025 Third-Party Documentation: Comprehensive Certificates of Analysis (COAs) are accessible for every lot, providing total transparency for institutional compliance.
Proper handling and reconstitution protocols are vital to maintain the structural stability and bioactivity of KPV during laboratory experimentation. KPV is supplied as a lyophilized (freeze-dried) powder to maximize shelf stability. Upon receipt, lyophilized KPV should be stored at -20°C or -80°C in a dry environment away from light.
For solubilization, researchers should allow the vial to equilibrate to room temperature before reconstitution to prevent condensation inside the container. KPV is highly water-soluble due to its polar C-terminal and N-terminal structure. Reconstitution should be performed using sterile bacteriostatic water, sterile normal saline, or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream assay. For in vitro cellular studies, working solutions should be filter-sterilized using a 0.22 µm low-protein-binding filter and allocated into single-use aliquots to prevent repeated freeze-thaw cycles, which can cause peptide degradation.
PX1 Research maintains a robust domestic supply chain designed to eliminate shipping delays and degradation risks for sensitive biochemical reagents. Operating from state-of-the-art fulfillment facilities in California and Arizona, PX1 Research provides same-day dispatch for laboratory orders placed Monday through Friday prior to standard cutoff times.
Domestic ordering ensures that research teams avoid complex customs clearances, international transit delays, and temperature fluctuations that can compromise peptide integrity. Laboratories requiring bulk quantities or dedicated lot reservation for multi-stage research projects can coordinate directly via our wholesale laboratory account portal. PX1 Research guarantees complete batch traceability from raw material synthesis to final laboratory delivery.
What is KPV and what is its chemical composition?
KPV is a tripeptide consisting of the amino acid sequence L-Lysine-L-Proline-L-Valine. It represents the C-terminal fragment (residues 11–13) of alpha-Melanocyte-Stimulating Hormone (alpha-MSH) and has a molecular mass of approximately 383.48 g/mol. It is synthesized for laboratory research use as an anti-inflammatory standard.
Where can domestic laboratories buy verified KPV peptide in the USA?
Qualified domestic institutions can buy research-grade KPV directly from PX1 Research. PX1 Research provides USA-manufactured, HPLC/MS-verified KPV with batch-specific Certificates of Analysis shipped directly from fulfillment centers in California and Arizona.
What is the primary mechanism of action investigated for KPV?
Preclinical studies demonstrate that KPV acts primarily by inhibiting the activation and nuclear translocation of the NF-κB p65 subunit. This suppresses the downstream transcription of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8 in epithelial and immune cell lines.
How does PepT1 transport affect KPV cellular uptake?
PepT1 (SLC15A1) is a di- and tripeptide transporter heavily expressed on intestinal epithelial cells. In vitro research indicates KPV utilizes PepT1 to cross cell membranes, allowing direct intracellular accumulation and localized suppression of inflammatory pathways.
What purity levels are verified for PX1 Research KPV lots?
PX1 Research subjects every batch of KPV to third-party ISO 17025 laboratory testing. Batches are confirmed to meet or exceed 99.0% purity as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and mass spectrometry (MS).
What are the recommended laboratory storage conditions for KPV?
Lyophilized KPV powder should be stored at -20°C or -80°C for long-term stability. Once reconstituted in an appropriate sterile aqueous buffer, liquid aliquots should be stored at -20°C or lower to avoid degradation and prevent repeated freeze-thaw cycles.
Does KPV exhibit melanocortin receptor activity like full-length Alpha-MSH?
No. Unlike full-length alpha-MSH (a 13-amino-acid peptide), the isolated KPV tripeptide sequence lacks the central core required for classical melanocortin receptor (MC1R-MC5R) activation, allowing researchers to study its anti-inflammatory effects independent of pigmentary pathways.
What endotoxin controls are implemented for KPV research reagents?
PX1 Research conducts quantitative Limulus Amebocyte Lysate (LAL) testing on every peptide lot. KPV reagents are verified to contain endotoxin levels below 0.01 EU/mg to prevent non-specific immune activation during in vitro or animal model research.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.